Long-term treatment of generalised anxiety disorder with Aviandr: results of a 36-week post-registration observational study

The management of patients with generalised anxiety disorder (GAD) is a pressing issue in modern medicine. A new Russian drug, Aviandr (maritupridine), has demonstrated efficacy and good tolerability in the treatment of GAD in clinical trials.Objective: To study the effectiveness of treating GAD wit...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	M. A. Kinkulkina, B. A. Volel, E. A. Smolyarchuk, E. N. Morozov, A. V. Ivaschenko, A. A. Ivaschenko, N. N. Ivanets, V. G. Zilov, T. I. Avdeeva, Yu. G. Tikhonova, T. A. Izyumina, P. A. Belyaeva, V. A. Dedkova, O. V. Izmailova, D. A. Golovkina, E. M. Goncharova, D. S. Gorchakov, A. E. Morozov, V. V. Tarasov
Format:	Artigo
Sprog:	Russo
Udgivet:	IMA-PRESS LLC 2025-12-01
Serier:	Неврология, нейропсихиатрия, психосоматика
Fag:	generalised anxiety disorder therapy aviandr efficacy anxiety depression cognitive impairment
Online adgang:	https://nnp.ima-press.net/nnp/article/view/2737
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!